# KLX Energy Services Holdings, Inc.: financial statements, quarterly

KLXE · Nasdaq · CIK 1738827 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/klxe.md) · [Financials](/companies/klxe/financials.md) · [Filings](/companies/klxe/filings.md) · [Insiders](/companies/klxe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/klxe/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [221](/filings/0001738827-24-000076.md) | [194 d](/filings/0001738827-25-000041.md) | [175](/filings/0001738827-25-000052.md) | [180](/filings/0001738827-25-000066.md) | [189](/filings/0001738827-25-000074.md) | [166 d](/filings/0001738827-26-000013.md) | [154](/filings/0001738827-26-000021.md) | [159](/filings/0001738827-26-000032.md) | [167](/filings/0001738827-25-000074.md) | [157 d](/filings/0001738827-26-000013.md) | [145](/filings/0001738827-26-000021.md) | [167](/filings/0001738827-26-000032.md) |
| Cost of revenue | $m | [166](/filings/0001738827-24-000076.md) | [152 d](/filings/0001738827-25-000041.md) | [144](/filings/0001738827-25-000052.md) | [136](/filings/0001738827-25-000066.md) | [142](/filings/0001738827-25-000074.md) | [127 d](/filings/0001738827-26-000013.md) | [124](/filings/0001738827-26-000021.md) | [126](/filings/0001738827-26-000032.md) | [131](/filings/0001738827-25-000074.md) | [122 d](/filings/0001738827-26-000013.md) | [119](/filings/0001738827-26-000021.md) | [131](/filings/0001738827-26-000032.md) |
| Research and development | $m | [0.4](/filings/0001738827-24-000076.md) | [0.4 d](/filings/0001738827-25-000041.md) | [0.3](/filings/0001738827-25-000052.md) | [0.3](/filings/0001738827-25-000066.md) | [0.4](/filings/0001738827-25-000074.md) | [0.4 d](/filings/0001738827-26-000013.md) | [0.4](/filings/0001738827-26-000021.md) | [0.4](/filings/0001738827-26-000032.md) | [0.4](/filings/0001738827-25-000074.md) | [0.5 d](/filings/0001738827-26-000013.md) | [0.4](/filings/0001738827-26-000021.md) | [0.5](/filings/0001738827-26-000032.md) |
| Selling, general and administrative | $m | [18.6](/filings/0001738827-24-000076.md) | [19.9 d](/filings/0001738827-25-000041.md) | [21.6](/filings/0001738827-25-000052.md) | [19.3](/filings/0001738827-25-000066.md) | [21.2](/filings/0001738827-25-000074.md) | [17.5 d](/filings/0001738827-26-000013.md) | [21.6](/filings/0001738827-26-000021.md) | [18.0](/filings/0001738827-26-000032.md) | [15.6](/filings/0001738827-25-000074.md) | [13.3 d](/filings/0001738827-26-000013.md) | [15.4](/filings/0001738827-26-000021.md) | [19.0](/filings/0001738827-26-000032.md) |
| Operating income | $m | [16.4](/filings/0001738827-24-000076.md) | [2.0 d](/filings/0001738827-25-000041.md) | [(13.1)](/filings/0001738827-25-000052.md) | [1.4](/filings/0001738827-25-000066.md) | [1.1](/filings/0001738827-25-000074.md) | [(4.9) d](/filings/0001738827-26-000013.md) | [(16.5)](/filings/0001738827-26-000021.md) | [(8.7)](/filings/0001738827-26-000032.md) | [(3.0)](/filings/0001738827-25-000074.md) | [(2.1) d](/filings/0001738827-26-000013.md) | [(12.1)](/filings/0001738827-26-000021.md) | [2.1](/filings/0001738827-26-000032.md) |
| Interest expense | $m | [9.2](/filings/0001738827-23-000075.md) | [9.3 d](/filings/0001738827-24-000038.md) | [9.6](/filings/0001738827-25-000052.md) | [9.8](/filings/0001738827-25-000066.md) | [9.8](/filings/0001738827-25-000074.md) | [10.2 d](/filings/0001738827-26-000013.md) | [10.3](/filings/0001738827-25-000052.md) | [11.0](/filings/0001738827-26-000032.md) | [11.1](/filings/0001738827-25-000074.md) | [12.8 d](/filings/0001738827-26-000013.md) | [11.7](/filings/0001738827-26-000021.md) | [12.5](/filings/0001738827-26-000032.md) |
| Income tax | $m | [0.3](/filings/0001738827-24-000076.md) | [2.8 d](/filings/0001738827-25-000041.md) | [0.2](/filings/0001738827-25-000052.md) | [0.2](/filings/0001738827-25-000066.md) | [0.2](/filings/0001738827-25-000074.md) | [0.0 d](/filings/0001738827-26-000013.md) | [0.2](/filings/0001738827-26-000021.md) | [0.2](/filings/0001738827-26-000032.md) | [0.2](/filings/0001738827-25-000074.md) | [0.2 d](/filings/0001738827-26-000013.md) | [0.2](/filings/0001738827-26-000021.md) | [(1.7)](/filings/0001738827-26-000032.md) |
| Net income | $m | [7.6](/filings/0001738827-24-000076.md) | [(9.2) d](/filings/0001738827-25-000041.md) | [(22.2)](/filings/0001738827-25-000074.md) | [(8.0)](/filings/0001738827-25-000074.md) | [(8.2)](/filings/0001738827-25-000074.md) | [(14.6) d](/filings/0001738827-26-000013.md) | [(27.9)](/filings/0001738827-26-000032.md) | [(19.9)](/filings/0001738827-26-000032.md) | [(14.3)](/filings/0001738827-25-000074.md) | [(15.0) d](/filings/0001738827-26-000013.md) | [(24.0)](/filings/0001738827-26-000032.md) | [(8.4)](/filings/0001738827-26-000032.md) |
| Diluted EPS | $ per share | [0.47](/filings/0001738827-24-000076.md) | not reported | [(1.38)](/filings/0001738827-25-000052.md) | [(0.49)](/filings/0001738827-25-000066.md) | [(0.51)](/filings/0001738827-25-000074.md) | not reported | [(1.62)](/filings/0001738827-26-000021.md) | [(1.04)](/filings/0001738827-26-000032.md) | [(0.74)](/filings/0001738827-25-000074.md) | not reported | [(1.23)](/filings/0001738827-26-000021.md) | [(0.41)](/filings/0001738827-26-000032.md) |
| Basic EPS | $ per share | [0.47](/filings/0001738827-24-000076.md) | not reported | [(1.38)](/filings/0001738827-25-000052.md) | [(0.49)](/filings/0001738827-25-000066.md) | [(0.51)](/filings/0001738827-25-000074.md) | not reported | [(1.62)](/filings/0001738827-26-000021.md) | [(1.04)](/filings/0001738827-26-000032.md) | [(0.74)](/filings/0001738827-25-000074.md) | not reported | [(1.23)](/filings/0001738827-26-000021.md) | [(0.41)](/filings/0001738827-26-000032.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [90.4](/filings/0001738827-23-000075.md) | [113](/filings/0001738827-25-000041.md) | [84.9](/filings/0001738827-24-000051.md) | [86.9](/filings/0001738827-24-000066.md) | [82.7](/filings/0001738827-24-000076.md) | [91.6](/filings/0001738827-26-000013.md) | [14.6](/filings/0001738827-25-000052.md) | [16.7](/filings/0001738827-25-000066.md) | [8.3](/filings/0001738827-25-000074.md) | [5.7](/filings/0001738827-26-000032.md) | [5.6](/filings/0001738827-26-000021.md) | [7.9](/filings/0001738827-26-000032.md) |
| Current assets | $m | [287](/filings/0001738827-23-000075.md) | [290](/filings/0001738827-25-000041.md) | [254](/filings/0001738827-24-000051.md) | [251](/filings/0001738827-24-000066.md) | [255](/filings/0001738827-24-000076.md) | [233](/filings/0001738827-26-000013.md) | [168](/filings/0001738827-25-000052.md) | [173](/filings/0001738827-25-000066.md) | [164](/filings/0001738827-25-000074.md) | [150](/filings/0001738827-26-000032.md) | [154](/filings/0001738827-26-000021.md) | [179](/filings/0001738827-26-000032.md) |
| Total assets | $m | [524](/filings/0001738827-23-000075.md) | [540](/filings/0001738827-25-000041.md) | [498](/filings/0001738827-24-000051.md) | [491](/filings/0001738827-24-000066.md) | [487](/filings/0001738827-24-000076.md) | [456](/filings/0001738827-26-000013.md) | [379](/filings/0001738827-25-000052.md) | [370](/filings/0001738827-25-000066.md) | [358](/filings/0001738827-25-000074.md) | [340](/filings/0001738827-26-000032.md) | [332](/filings/0001738827-26-000021.md) | [372](/filings/0001738827-26-000032.md) |
| Current liabilities | $m | [153](/filings/0001738827-23-000075.md) | [164](/filings/0001738827-25-000041.md) | [147](/filings/0001738827-24-000051.md) | [152](/filings/0001738827-24-000066.md) | [205](/filings/0001738827-24-000076.md) | [140](/filings/0001738827-26-000013.md) | [111](/filings/0001738827-25-000052.md) | [139](/filings/0001738827-25-000066.md) | [137](/filings/0001738827-25-000074.md) | [126](/filings/0001738827-26-000032.md) | [123](/filings/0001738827-26-000021.md) | [152](/filings/0001738827-26-000032.md) |
| Long-term debt | $m | [284](/filings/0001738827-23-000075.md) | [284](/filings/0001738827-25-000041.md) | [285](/filings/0001738827-24-000051.md) | [285](/filings/0001738827-24-000066.md) | [235](/filings/0001738827-24-000076.md) | [285](/filings/0001738827-26-000013.md) | [257](/filings/0001738827-25-000052.md) | [254](/filings/0001738827-25-000066.md) | [255](/filings/0001738827-25-000074.md) | [254](/filings/0001738827-26-000032.md) | [271](/filings/0001738827-26-000021.md) | [284](/filings/0001738827-26-000032.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001738827-24-000076.md) | not reported | not reported | [50.0](/filings/0001738827-24-000076.md) | [0.0](/filings/0001738827-26-000013.md) | [4.3](/filings/0001738827-25-000052.md) | [4.5](/filings/0001738827-25-000066.md) | [4.5](/filings/0001738827-25-000074.md) | [4.4](/filings/0001738827-26-000032.md) | [4.5](/filings/0001738827-26-000021.md) | [4.6](/filings/0001738827-26-000032.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [2.7](/filings/0001738827-24-000076.md) | [1.9](/filings/0001738827-25-000041.md) | [0.6](/filings/0001738827-25-000052.md) | [4.9](/filings/0001738827-25-000066.md) | [2.9](/filings/0001738827-25-000074.md) | [1.9](/filings/0001738827-26-000013.md) | [0.5](/filings/0001738827-26-000021.md) | [12.3](/filings/0001738827-26-000032.md) |
| Shareholders' equity | $m | [47.8](/filings/0001738827-24-000076.md) | [38.8](/filings/0001738827-26-000013.md) | [16.9](/filings/0001738827-25-000074.md) | [9.8](/filings/0001738827-25-000074.md) | [2.5](/filings/0001738827-25-000074.md) | [(10.5)](/filings/0001738827-26-000032.md) | [(26.6)](/filings/0001738827-26-000032.md) | [(47.2)](/filings/0001738827-26-000032.md) | [(61.2)](/filings/0001738827-25-000074.md) | [(74.2)](/filings/0001738827-26-000032.md) | [(96.1)](/filings/0001738827-26-000032.md) | [(102)](/filings/0001738827-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.6 d](/filings/0001738827-24-000076.md) | [38.6 d](/filings/0001738827-25-000041.md) | [(10.8)](/filings/0001738827-25-000052.md) | [22.2 d](/filings/0001738827-25-000066.md) | [16.8 d](/filings/0001738827-25-000074.md) | [26.0 d](/filings/0001738827-26-000013.md) | [(37.6)](/filings/0001738827-26-000021.md) | [19.1 d](/filings/0001738827-26-000032.md) | [13.5 d](/filings/0001738827-25-000074.md) | [12.5 d](/filings/0001738827-26-000013.md) | [0.3](/filings/0001738827-26-000021.md) | [10.5 d](/filings/0001738827-26-000032.md) |
| Capital expenditure | $m | [17.8](/filings/0001738827-24-000076.md) | [12.8 d](/filings/0001738827-25-000041.md) | [13.5](/filings/0001738827-25-000052.md) | [15.3](/filings/0001738827-25-000066.md) | [21.0](/filings/0001738827-25-000074.md) | [15.3 d](/filings/0001738827-26-000013.md) | [15.0](/filings/0001738827-26-000021.md) | [12.7](/filings/0001738827-26-000032.md) | [12.0](/filings/0001738827-25-000074.md) | [9.4 d](/filings/0001738827-26-000013.md) | [8.7](/filings/0001738827-26-000021.md) | [8.6](/filings/0001738827-26-000032.md) |
| Share repurchases | $m | [0.0 d](/filings/0001738827-24-000076.md) | not reported | [0.5](/filings/0001738827-24-000051.md) | [0.0 d](/filings/0001738827-24-000066.md) | [(0.1) d](/filings/0001738827-24-000076.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.5](/filings/0001738827-23-000075.md) | [14.4](/filings/0001738827-24-000051.md) | [16.1](/filings/0001738827-24-000066.md) | [16.1](/filings/0001738827-24-000076.md) | [16.1](/filings/0001738827-25-000052.md) | [16.2](/filings/0001738827-25-000066.md) | [16.2](/filings/0001738827-25-000074.md) | [17.2](/filings/0001738827-26-000021.md) | [19.2](/filings/0001738827-26-000032.md) | [19.2](/filings/0001738827-25-000074.md) | [19.5](/filings/0001738827-26-000021.md) | [20.5](/filings/0001738827-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,273,059 at 2026-07-31, from the cover of the [10-Q filed 2026-08-11](/filings/0001738827-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.